CompoAtlas

宇強大豆萃取 (含大豆異黃酮) 複方膠囊食品

宇強大豆萃取 (含大豆異黃酮) 複方膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1110711554
Chinese name
宇強大豆萃取 (含大豆異黃酮) 複方膠囊食品
English name
YUU CHIARNG LADY CAPSULE
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
安利行有限公司
Registration date
2022-06-01
Published validity end
2027-06-01

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
SOY EXTRACTSOY EXTRACTNot identified
VACCINIUM MACROCARPONVACCINIUM MACROCARPONNot identified
COLLAGENCOLLAGENCollagène
PEARL POWDERPEARL POWDERNot identified
CYANOCOBALAMINCYANOCOBALAMINVitamine B12
ZIZIPHUS JUJUBA MILLZIZIPHUS JUJUBA MILLNot identified
EVENING PRIMROSE SEED OILEVENING PRIMROSE SEED OILNot identified
BORAGE SEED OILBORAGE SEED OILNot identified
ANGELICA SINENSIS DIELSANGELICA SINENSIS DIELSNot identified
GREEN OAT EXTRACT POWDERGREEN OAT EXTRACT POWDERNot identified
RICE BRANRICE BRANNot identified
BROMELAINBROMELAINNot identified
COIX LACRYMA-JOBI L. VAR. MA-YUEN STAPFCOIX LACRYMA-JOBI L. VAR. MA-YUEN STAPFNot identified
PAPAINPAPAINNot identified
ASCORBIC ACIDASCORBIC ACIDVitamine C
FOLIC ACIDFOLIC ACIDFolates (vitamine B9)
CALCIUM CITRATECALCIUM CITRATECalcium
CHOLECALCIFEROLCHOLECALCIFEROLVitamine D
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
WATERWATERNot identified
COCHINEAL RED ACOCHINEAL RED ANot identified
SORBIC ACIDSORBIC ACIDNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
宇強大豆萃取 (含大豆異黃酮) 複方膠囊食品
Active ingredients
SOY EXTRACT;;VACCINIUM MACROCARPON;;COLLAGEN;;PEARL POWDER;;CYANOCOBALAMIN;;ZIZIPHUS JUJUBA MILL;;EVENING PRIMROSE SEED OIL;;BORAGE SEED OIL;;ANGELICA SINENSIS DIELS;;GREEN OAT EXTRACT POWDER;;RICE BRAN;;BROMELAIN;;COIX LACRYMA-JOBI L. VAR. MA-YUEN STAPF;;PAPAIN;;ASCORBIC ACID;;FOLIC ACID;;CALCIUM CITRATE;;CHOLECALCIFEROL;;GELATIN;;GLYCEROL;;WATER;;COCHINEAL RED A;;SORBIC ACID;;
Valid until
1160601
Registration number
1110711554
Licence holder
安利行有限公司
Registration date
1110601
Published reference
DHC0B107115541
Published English name
YUU CHIARNG LADY CAPSULE

Official source

View the official register, number 1110711554

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • VACCINIUM MACROCARPON
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • CHOLECALCIFEROL
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line